NYSE:AGL - agilon health Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $40.20
  • Forecasted Upside: 67.78 %
  • Number of Analysts: 11
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 11 Buy Ratings
  • 0 Strong Buy Ratings
$23.96
▲ +0.23 (0.97%)

This chart shows the closing price for AGL by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New agilon health Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AGL and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AGL

Analyst Price Target is $40.20
▲ +67.78% Upside Potential
This price target is based on 11 analysts offering 12 month price targets for agilon health in the last 3 months. The average price target is $40.20, with a high forecast of $45.00 and a low forecast of $35.00. The average price target represents a 67.78% upside from the last price of $23.96.

This chart shows the closing price for AGL for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 11 contributing investment analysts is to buy stock in agilon health.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/25/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/23/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/21/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/21/2021
  • 0 strong buy ratings
  • 9 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/20/2021
  • 0 strong buy ratings
  • 10 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/18/2021
  • 0 strong buy ratings
  • 11 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/18/2021

Latest Recommendations

  • 0 strong buy ratings
  • 11 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/13/2021Truist SecuritiesLower Price TargetBuy$41.00 ➝ $35.00High
10/13/2021TruistLower Price TargetBuy$41.00 ➝ $35.00Low
9/27/2021SVB LeerinkInitiated CoverageOutperform$37.00High
9/9/2021CowenInitiated CoverageOutperform$44.00High
6/3/2021Wells Fargo & CompanyBoost Price TargetOverweight$38.00 ➝ $44.00Medium
5/28/2021Deutsche Bank AktiengesellschaftBoost Price TargetBuy$42.00 ➝ $45.00Medium
5/10/2021William BlairInitiated CoverageOutperformMedium
5/10/2021Wolfe ResearchInitiated CoverageOutperform$37.00Low
5/10/2021Truist SecuritiesInitiated CoverageBuy$40.00Medium
5/10/2021JPMorgan Chase & Co.Initiated CoverageOverweight$42.00Low
5/10/2021Deutsche Bank AktiengesellschaftInitiated CoverageBuy$42.00Low
5/10/2021Bank of AmericaInitiated CoverageBuy$41.00Low
5/10/2021The Goldman Sachs GroupInitiated CoverageBuy$42.00Low
5/10/2021TruistInitiated CoverageBuy$40.00Low
5/10/2021Wells Fargo & CompanyInitiated CoverageOverweight$38.00Low
(Data available from 10/18/2016 forward)

News Sentiment Rating

0.59 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/22/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/21/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/21/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/20/2021
  • 3 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/20/2021
  • 2 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/19/2021
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/18/2021
  • 8 very positive mentions
  • 13 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
10/18/2021

Current Sentiment

  • 8 very positive mentions
  • 13 positive mentions
  • 4 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.
agilon health logo
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Long Beach, California.
Read More

Today's Range

Now: $23.96
Low: $23.65
High: $24.55

50 Day Range

MA: $31.03
Low: $23.41
High: $37.75

52 Week Range

Now: $23.96
Low: $20.81
High: $44.83

Volume

3,252,000 shs

Average Volume

833,224 shs

Market Capitalization

$9.37 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of agilon health?

The following Wall Street research analysts have issued reports on agilon health in the last twelve months: Bank of America Co., Cowen Inc, Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., SVB Leerink LLC, The Goldman Sachs Group, Inc., Truist, Truist Securities, Wells Fargo & Company, William Blair, Wolfe Research, and Zacks Investment Research.
View the latest analyst ratings for AGL.

What is the current price target for agilon health?

10 Wall Street analysts have set twelve-month price targets for agilon health in the last year. Their average twelve-month price target is $40.20, suggesting a possible upside of 67.8%. Deutsche Bank Aktiengesellschaft has the highest price target set, predicting AGL will reach $45.00 in the next twelve months. Truist has the lowest price target set, forecasting a price of $35.00 for agilon health in the next year.
View the latest price targets for AGL.

What is the current consensus analyst rating for agilon health?

agilon health currently has 11 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe AGL will outperform the market and that investors should add to their positions of agilon health.
View the latest ratings for AGL.

How do I contact agilon health's investor relations team?

The official website for agilon health is agilonhealth.com.